403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Orogen Royalties Inc.
(MENAFN- Baystreet) 10:07 AM EST - Orogen Royalties Inc. : Announces that, as part of the Company's annual share-based compensation program, the Board of Directors have authorized a grant of 324,000 Restricted Share Units (RSUs), 62,000 Deferred Share Units (DSUs), and 977,000 incentive Stock Options to directors, officers, employees, and consultants. The grant has been authorized pursuant to the Company's Omnibus Equity Incentive Compensation Plan that was approved by shareholders October 29, 2024. Orogen Royalties Inc.
shares V are trading unchanged at $1.51.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research
More Story
Comments
No comment